This page includes the latest FDA filings for Clarus Therapeutics Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Device Company | Device | Date |
|---|---|---|
| TOLMAR Inc. | Prescription Medication | 2025-09-17 |
| TOLMAR Inc. | Prescription Medication | 2025-07-25 |
| TOLMAR Inc. | Prescription Medication | 2025-06-03 |
| TOLMAR Inc. | Prescription Medication | 2025-05-22 |
| TOLMAR Inc. | Prescription Medication | 2025-03-31 |
| TOLMAR Inc. | Prescription Medication | 2023-08-14 |
| TOLMAR Inc. | Prescription Medication | 2022-12-08 |
| TOLMAR Inc. | Prescription Medication | 2021-01-12 |
| TOLMAR Inc. | Prescription Medication | 2019-09-28 |
| Clarus Therapeutics, Inc. | Jatenzo | 2019-08-01 |
| Clarus Therapeutics, Inc. | Jatenzo | 2019-08-01 |
| Clarus Therapeutics, Inc. | Jatenzo | 2019-08-01 |
| NCAGE Code | 8GCE8 | CLARUS THERAPEUTICS, INC. |
| CAGE Code | 8GCE8 | CLARUS THERAPEUTICS, INC. |
| S.A.M. Registration | 8GCE8 [556777469] | CLARUS THERAPEUTICS, INC. |
| SEC | 0001286162 | CLARUS THERAPEUTICS INC |